Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4+-cell depleted, athymic and NK-cell depleted SCID mice

Inflammation Research

Volumn 45, Issue 4, 1996, Pages 181-191

  Axelsson, L G ^a,b   Landstrom E ^b   Goldschmidt, T J ^c   Gronberg A ^b   Bylund Fellenius, A C ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Dextran sulfate; Disease models; Immunocompromised; Mice; Ulcerative colitis

Indexed keywords

ANTIBODY; CD4 ANTIGEN; DEXTRAN SULFATE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; COLITIS; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE; THYMECTOMY;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; B-LYMPHOCYTES; BODY WEIGHT; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; G(M1) GANGLIOSIDE; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; ORGAN SIZE; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, HELPER-INDUCER; THYMECTOMY;

EID: 0029918501     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02285159     Document Type: Article

References (48)

1. Jewell DP, Chapman RGW, Mortensen N. Ulcerative colitis and Crohn's disease, a clinicians guide. London: Churchill Livingstone, 1992:79.
2. Snook J. Are the inflammatory bowel diseases autoimmune disorders. Gut 1990;31:961-3.
3. Raedler A, Schreiber S. Ist die Colitis ulcerosa eine Autoimmunerkrankung? Dtsch Med Wochenschr 1992;117:1333-8.
4. Brandtzaeg P. Autoimmunity and ulcerative colitis. Can two enigmas make sense together? Gastroenterology 1995;109:307-22.
5. Axelsson LG, Ahlstedt S. Actions of sulphasalazine and analogues in animal models of experimental colitis. Inflammopharmacology 1993;2:219-32.
6. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
7. Axelsson L-G, Landström E, Bylund-Fellenius A-C. Effects of sulfasalazine on survival of athymic mice with dextran sulfate (DSS) induced colitis. Gut 1992;Suppl 33:S39.
8. Axelsson LG, Landström E, Bylund-Fellenius AC. Sulfasalazine and olsalazine are effective for the treatment of dextran sulfate induced colitis in athymic mice. Gastroenterology 1994;106: 648.
9. Kimura I, Kamiya A, Nagahama S, Yoshida J, Tanigawa H, Kataoka M. Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rats: Estimation of mucosal erosions by the alcian blue-staining method. Folia Pharmacol Jpn 1993;102:343-50.
10. Kimura I, Nagahama S, Kawasaki M, Kamiya A, Kataoka M. Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (2). Folia Pharmacol Jpn 1995;105:145-52.
11. Nakamaru K, Sugai K, Hongyo T, Sato M, Taniguchi S, Tanaka Y, et al. Effect of mesalazine microgranules on experimental colitis. Folia Pharmacol Jpn 1994;104:303-10.
12. Zijlstra FJ, Garrelds IM, van Dijk APM, Wilson JHP. Experimental colitis in mice: Effects of olsalazine on eicosanoid production in colonic tissue. Agents Actions 1992:C76-8.
13. Greenfield SM, Punchard NA, Teare J-P, Thompson RPH. Review article: the mode of action of the aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 1993;7:369-83.
14. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clincopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
15. Bylund-Fellenius A-C, Landström E, Axelsson L-G, Midtvedt T. Experimental colitis induced by dextran sulphate in normal and germfree mice. Microb Ecol Health Dis 1994;7:207-15.
16. Buell MG, Merin MC. Neutrophil-independency of the initiation of colonic injury: Comparison of results from three models of experimental colitis in the rat. Dig Dis Sci 1994;39:2575-88.
17. Murthy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993;38:1722-34.
18. Ohkusa T, Yamada M, Takenaga T. Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium. Jpn J Gastroenterol 1987;84:2337-46.
19. Weldon MJ, Maxwell JD. Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy? Gut 1994;35:867-71.
20. +) subsets among anti-Ia cytolytic T cell clones. J Immunol 1984;132:2775-82.
21. Lanier LL, Gutman GA, Lewis DE, Griswold ST, Warner NL. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma 1982;1:125-31.
22. Goldschmidt TJ, Holmdahl R, Klareskog L. Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat k chain antibody. Journal Immunol Meth 1988;111:219-26.
23. Grönberg A, Kiessling R, Eriksson E, Hansson M. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis. J Immunol 1981;127:1734-9.
24. Axelsson L-G, Ahlstedt S. A fluorescence method for the visualization of inflammatory cells in intestinal mucosa. J Immunol Methods 1990;127:271-7.
25. Cary NC. SAS/STAT Users Guide. 4th ed. vol 2. SAS Institute Inc., 1989.
26. Ishioka T, Kuwabara N, Oohasi Y, Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. CRC Crit Rev Toxicol 1987;17:215-44.
27. Hirono I, Kuhara K, Hosaka S, Tomizawa S, Goldberg L. Induction of intestinal tumors in rats by dextran sulfate sodium. J Natl Cancer Inst 1981;66(7):579-83.
28. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993;342:407-11.
29. Guy-Grand D, Vasalli P. Gut intraepithelial T lymphocytes. Curr Opin Immunol 1993;5:247.
30. Hörnqvist E, Goldschmidt T, Holmdahl R, Lycke N. Host defense against cholera toxin is strongly CD4+ T cell dependent. Infect Immun 1991;59:3630-8.
31. + cell function in vivo? Immunol Today 1988;9:165-8.
32. Strober W, Ehrhardt RO. Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993;75:203-5.
33. Macdonald HR, Blanc C, Lees RK, Sordat B. Abnormal distribution of T cell subsets in athymic mice. J Immunol 1986;136:4337-9.
34. Lake JP, Pierce CW, Kennedy JD. T cell receptor expression by T cells that mature extrathymically in nude mice. Cell Immunol 1991;135:259-65.
35. Lake JP, Pierce CW, Kennedy JD. CD8 + α/β or γ/δ T cell receptor-bearing T cells from athymic nude mice are cytolytically active in vivo. J Immunol 1991;147:1121-6.
36. + cells responsible for acute marrow graft rejection are present in thymus-deficient mice. J Immunol 1992;149:403-12.
37. Rogers HW, Tripp CS, Schreiber RD, Unanue ER. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine Listeriosis. J Immunol 1994;153:2093-101.
38. Coutinho A, Möller G, Richter W. Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol 1974;3:321-38.
39. Gronowicz E, Biberfeld P, Wahren B, Coutinho A. Characterization of dextran-sulfate-sensitive cells. Scand J Immunol 1976;5:573-82.
40. Persson UCI, Hammarström LG, Smith CIE. Macrophages are required for the dextran-sulfate induced activation of B lymphocytes. J Immunol 1977;119:1138-44.
41. Kishimoto S, Kobayashi H, Shimizu S, Haruma K, Tamaru T, Kajiyama G, et al. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis. Dig Dis Sci 1992;37:1729-37.
42. Fiebig E, Ley K, Arfors K-E. Rapid leukocyte accumulation by "spontaneous" rolling and adhesion in the exteriorized rabbit mesentery. Int J Microcirc: Clin Exp 1991;10:127-44.
43. Chen Y, Conner EM, Grisham MB. Dextran sodium (DSS)-induces colitis in rats by enhancing mucosal permeability: Effects of sulfasalazine. Gastroenterology 1995;108:796.
44. Chen Y, Grisham MB. Effect of dextran sulfate sodium on the proliferative activity of intestinal crypt epithelial cells. Gastroenterology 1994;106:663.
45. Kamochi M, Ogata M, Yoshida S, Matsumoto T, Kubota E, Mizuguchi Y, et al. Dextran sulphate enhancement of lipopolysaccharide-induced tumour necrosis factor-α production by murine peritoneal macrophages: Correlation with macrophage blockade. FEMS Immunol Med Microbiol 1993;7:153-60.
46. Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995;63:865-73.
47. Axelsson L-G, Landström E, Bylund-Fellenius A-C, Midtvedt T. Dextran sulfate sodium induced colitis and sulfasalazine treatment in bacteria-free mice. Gastroenterology 1995;108: 775.
48. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroent Hepatol 1995;10:387-95.